ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002